IP Library Granted Patent US 12,559,799
Granted Patent B2
US 12,559,799 · App. 17/586,143 · Granted Feb 24, 2026

Methods for the detection of genomic copy changes in DNA samples

Inventors: Christopher Raymond (Kirkland, WA); Lee Lim (Kirkland, WA); Jennifer Hernandez (Kirkland, WA)
Assignee: Resolution Bioscience, Inc.
C12Q1/6886C12Q1/68C12Q1/6806C12Q1/6809C12Q1/686C12Q1/6869G16B20/00G16B20/10G16B20/20G16B20/40G16B25/10G16B30/00G16B30/10C12Q1/6851C12Q2525/191C12Q2545/114C12Q2563/159C12Q2563/179C12Q2600/156C40B40/08G01N2570/00G01N2800/7028
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,559,799
App. No.
17/586,143
Granted
Feb 24, 2026
Kind
B2
Abstract

The present invention includes compositions and methods useful for the detection of a mutational change, SNP, translocation, inversion, deletion, change in copy number, or other genetic variation within a sample of cellular genomic DNA or cell-free DNA (cfDNA). In some embodiments, the compositions and methods of the present invention provide an extremely high level of resolution that is particularly useful in detecting copy number variations in a small fraction of the total cfDNA from a biological sample (e.g., blood).

Claims (46)

1 . A kit comprising a set of adaptors,

wherein each adaptor of the set of adaptors comprises a sample tag region selected from a pool of unique sample tag regions, wherein the pool is selected from a plurality of pools, and wherein the selected pool is unique to a test sample;

wherein the test sample comprises a plurality of DNA fragments;

wherein each adaptor of the set of adaptors is a DNA polynucleotide that comprises (i) an amplification region, (ii) a sample tag region; and (iii) an anchor region; and

wherein each adaptor of the set of adaptors further comprises a unique molecule identifier multiplier (UMI multiplier) that increases the number of unique sequences for identifying the plurality of DNA fragments.

2 . The kit of claim 1 , wherein the amplification region comprises a polynucleotide sequence capable of serving as a primer recognition site for PCR amplification.

3 . The kit of claim 1 , wherein the sample tag region identifies the test sample.

4 . The kit of claim 1 , wherein the anchor region comprises a polynucleotide sequence that is capable of attaching to a DNA fragment.

5 . The kit of claim 1 , wherein each adaptor of the set of adaptors is configured to attach to a DNA fragment of the plurality of DNA fragments to generate a DNA library comprising at least two unique sample tag regions, wherein each of the DNA library fragments comprises a DNA fragment attached to an adaptor.

6 . The kit of claim 1 , wherein the test sample is a tissue biopsy.

7 . The kit of claim 1 , wherein the DNA fragments are cell-free DNA (cfDNA) or cellular DNA.

8 . The kit of claim 1 , wherein the DNA fragments are genomic DNA.

9 . The kit of claim 7 , wherein the DNA fragments are isolated from the test sample; and wherein the test sample is a biological sample selected from the group consisting of: amniotic fluid, blood, plasma, serum, semen, lymphatic fluid, cerebral spinal fluid, ocular fluid, urine, saliva, stool, mucous, and sweat.

10 . The kit of claim 1 , wherein the amplification region of each adaptor of the set of adaptors is identical to the amplification region of every other adaptor of the set of adaptors.

11 . The kit of claim 1 , wherein the sample tag region identifies the DNA fragment attached thereto.

12 . The kit of claim 1 , wherein the UMI multiplier is adjacent to or contained within the sample tag region.

13 . The kit of claim 1 , wherein the pool of sample tag regions comprises between 2 and 1,000 unique sample tag region sequences.

14 . The kit of claim 1 , further comprising one or more capture probe modules.

15 . The kit of claim 14 , wherein each capture probe module comprises a tail sequence and a capture probe sequence capable of hybridizing to a target sequence in the test sample.

16 . A DNA library, wherein the DNA library comprises a plurality of DNA library fragments, wherein each of the DNA library fragments comprises an adaptor and a DNA fragment,

wherein the adaptor is a DNA polynucleotide comprising (i) an amplification region, (ii) a sample tag region, and (iii) an anchor region;

wherein the amplification region comprises a polynucleotide sequence capable of serving as a primer recognition site for PCR amplification;

wherein the sample tag region identifies the test sample;

wherein the anchor region comprises a polynucleotide sequence that is capable of attaching to a DNA fragment; and

wherein each adaptor of the set of adaptors further comprises a unique molecule identifier multiplier (UMI multiplier) that increases the number of unique sequences for identifying the plurality of DNA library fragments.

17 . A method for genetic analysis of a DNA target region comprising:

(a) generating a DNA library using the kit of claim 5 , wherein the DNA library comprises cfDNA;

(b) contacting the DNA library with a plurality of capture probe modules that specifically bind to a DNA target region, thereby forming complexes between the capture probe modules and DNA library fragments comprising the DNA target region; and

(c) performing a quantitative genetic analysis of the DNA library fragments comprising the DNA target region;

thereby performing genetic analysis of the DNA target region.

18 . A method of predicting, diagnosing, or monitoring a genetic disease in a subject comprising:

(a) obtaining a test sample from a subject;

(b) isolating DNA from the test sample;

(c) generating a DNA library comprising a plurality of DNA library fragments using the kit of claim 5 , wherein each of the DNA library fragments comprises a DNA fragment from the test sample and an adaptor;

(d) contacting the DNA library with a plurality of capture probe modules that specifically bind to a DNA target region, thereby forming complexes between the capture probe modules and DNA library fragments comprising the DNA target region; and

(e) performing a quantitative genetic analysis of one or more target genetic loci associated with the genetic disease in the DNA library, wherein the identification or detection of one or more genetic lesions in the one or more target genetic loci is prognostic for, diagnostic of, or monitors the progression of the genetic disease.

19 . A set of adaptors,

wherein each adaptor of the set of adaptors comprises a sample tag region selected from a pool of unique sample tag regions, wherein the pool is selected from a plurality of pools, and wherein the selected pool is unique to a test sample;

wherein each adaptor in said set of adapters is a DNA polynucleotide that comprises: an amplification region, a sample tag region, and an anchor region;

wherein the amplification region comprises a polynucleotide sequence capable of serving as a primer recognition site for PCR amplification;

wherein the sample tag region identifies the test sample;

wherein the anchor region comprises a polynucleotide sequence that is capable of attaching to a DNA fragment; and

wherein each adaptor of the set of adaptors further comprises a unique molecule identifier multiplier (UMI multiplier) that increases the number of unique sequences for identifying the plurality of DNA fragments.

20 . The set of adaptors of claim 19 , wherein the UMI multiplier is adjacent to or contained within the sample tag region.

21 . The set of adaptors of claim 19 , wherein the sample tag region identifies the DNA fragment attached thereto.

22 . The set of adaptors of claim 19 , wherein the pool of sample tag regions comprises between 2 and 1,000 unique sample tag region sequences.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2022
From: RAYMOND, CHRISTOPHER K.; LIM, LEE P.; HERNANDEZ, JENNIFER
To: RESOLUTION BIOSCIENCE, INC.
Reel/Frame 059013/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2022
From: RAYMOND, CHRISTOPHER K.; LIM, LEE P.; HERNANDEZ, JENNIFER
To: RESOLUTION BIOSCIENCE, INC.
Reel/Frame 059013/0804 →
Continuity (4)
Continuation 15685834 · Aug 24, 2017
Provisional Application 62481538 · Apr 4, 2017
Provisional Application 62379593 · Aug 25, 2016
Related Publication 20220325353A1 · Oct 13, 2022
References Cited (337)
US 5185243A · Ullman et al. · 1993 [cited by applicant]
US 5512445A · Yang et al. · 1996 [cited by applicant]
US 5514551A · Yang et al. · 1996 [cited by applicant]
US 5591582A · Bos et al. · 1997 [cited by applicant]
US 6025133A · Stull et al. · 2000 [cited by applicant]
US 6025139A · Yager et al. · 2000 [cited by applicant]
US 6087133A · Dattagupta et al. · 2000 [cited by applicant]
US 6214587B1 · Dattagupta et al. · 2001 [cited by applicant]
US 6480791B1 · Strathmann · 2002 [cited by applicant]
US 6812341B1 · Conrad · 2004 [cited by applicant]
US 7081527B2 · Cunningham et al. · 2006 [cited by applicant]
US 7393665B2 · Brenner · 2008 [cited by applicant]
US 7537897B2 · Brenner et al. · 2009 [cited by applicant]
US 7585631B2 · Cunningham et al. · 2009 [cited by applicant]
US 8148068B2 · Brenner · 2012 [cited by applicant]
US 8168385B2 · Brenner · 2012 [cited by applicant]
US 8318433B2 · Brenner · 2012 [cited by applicant]
US 8370079B2 · Sorenson et al. · 2013 [cited by applicant]
US 8383338B2 · Kitzman et al. · 2013 [cited by applicant]
US 8470996B2 · Brenner · 2013 [cited by applicant]
US 8476018B2 · Brenner · 2013 [cited by applicant]
US 8481292B2 · Casbon et al. · 2013 [cited by applicant]
US 8722368B2 · Casbon et al. · 2014 [cited by applicant]
US 8741811B2 · Lo et al. · 2014 [cited by applicant]
US 8828688B2 · Namsaraev · 2014 [cited by applicant]
US 8835358B2 · Fodor et al. · 2014 [cited by applicant]
US 8865410B2 · Shendure et al. · 2014 [cited by applicant]
US 8999642B2 · Sabot et al. · 2015 [cited by applicant]
US 9018365B2 · Brenner · 2015 [cited by applicant]
US 9085798B2 · Chee · 2015 [cited by applicant]
US 9121069B2 · Lo et al. · 2015 [cited by applicant]
US 9216172B2 · Kohno et al. · 2015 [cited by applicant]
US 9290808B2 · Fodor et al. · 2016 [cited by applicant]
US 9290809B2 · Fodor et al. · 2016 [cited by applicant]
US 9297011B2 · Downing et al. · 2016 [cited by applicant]
US 9315857B2 · Fu et al. · 2016 [cited by applicant]
US 9340830B2 · Lipson et al. · 2016 [cited by applicant]
US 9410954B2 · Boshoff et al. · 2016 [cited by applicant]
US 9522125B1 · Yao et al. · 2016 [cited by applicant]
US 9546399B2 · Amorese et al. · 2017 [cited by applicant]
US 9598731B2 · Talasaz · 2017 [cited by applicant]
US 9624489B2 · Sabot et al. · 2017 [cited by applicant]
US 9702002B2 · Boutell · 2017 [cited by applicant]
US 9708659B2 · Fodor et al. · 2017 [cited by applicant]
US 9783847B2 · Chee · 2017 [cited by applicant]
US 9783853B2 · Chinnaiyan et al. · 2017 [cited by applicant]
US 9792403B2 · Sun et al. · 2017 [cited by applicant]
US 9816137B2 · Fodor et al. · 2017 [cited by applicant]
US 9834822B2 · Talasaz · 2017 [cited by applicant]
US 9840743B2 · Talasaz · 2017 [cited by applicant]
US 9850523B1 · Chudova et al. · 2017 [cited by applicant]
US 9902992B2 · Talasaz et al. · 2018 [cited by applicant]
US 9907798B2 · Boshoff et al. · 2018 [cited by applicant]
US 9920366B2 · Eltoukhy et al. · 2018 [cited by applicant]
US 9932576B2 · Raymond et al. · 2018 [cited by applicant]
US 9965585B2 · Lo et al. · 2018 [cited by applicant]
US 10000800B2 · Chee · 2018 [cited by applicant]
US 10000814B2 · Cronin et al. · 2018 [cited by applicant]
US 10011870B2 · Zimmermann et al. · 2018 [cited by applicant]
US 10047394B2 · Fodor et al. · 2018 [cited by applicant]
US 10059991B2 · Fodor et al. · 2018 [cited by applicant]
US 10087482B2 · Korfhage et al. · 2018 [cited by applicant]
US 10095831B2 · Duenwald et al. · 2018 [cited by applicant]
US 10119165B2 · Chee · 2018 [cited by applicant]
US 10202646B2 · Fodor et al. · 2019 [cited by applicant]
US 10208296B2 · Iavarone et al. · 2019 [cited by applicant]
US 10208354B2 · Fernandez-Cuesta et al. · 2019 [cited by applicant]
US 10227587B2 · Zhang et al. · 2019 [cited by applicant]
US 10240209B2 · Lo et al. · 2019 [cited by applicant]
US 10266883B2 · Chee · 2019 [cited by applicant]
US 10266889B2 · Behlke et al. · 2019 [cited by applicant]
US 10287630B2 · Xie et al. · 2019 [cited by applicant]
US 10297342B2 · Lo et al. · 2019 [cited by applicant]
US 10329627B1 · Beeler et al. · 2019 [cited by applicant]
US 10378063B2 · Stransky et al. · 2019 [cited by applicant]
US 10378064B1 · Schutz et al. · 2019 [cited by applicant]
US 10388403B2 · Rava et al. · 2019 [cited by applicant]
US 10392661B2 · Fodor et al. · 2019 [cited by applicant]
US 10407509B2 · Stransky et al. · 2019 [cited by applicant]
US 10453556B2 · Lo et al. · 2019 [cited by applicant]
US 10494678B2 · Talasaz · 2019 [cited by applicant]
US 10501793B2 · Chee · 2019 [cited by applicant]
US 10501810B2 · Talasaz · 2019 [cited by applicant]
US 10538759B2 · Stuelpnagel et al. · 2020 [cited by applicant]
US 10577601B2 · Shendure et al. · 2020 [cited by applicant]
US 10597653B2 · Sabot et al. · 2020 [cited by applicant]
US 10597708B2 · Zimmermann et al. · 2020 [cited by applicant]
US 10597709B2 · Zimmermann et al. · 2020 [cited by applicant]
US 10619203B2 · Fodor et al. · 2020 [cited by applicant]
US 10619214B2 · Lo et al. · 2020 [cited by applicant]
US 10689699B2 · Salk et al. · 2020 [cited by applicant]
US 10704085B2 · Talasaz et al. · 2020 [cited by applicant]
US 10704086B2 · Talasaz et al. · 2020 [cited by applicant]
US 10705087B2 · Takeuchi et al. · 2020 [cited by applicant]
US 10741270B2 · Lo et al. · 2020 [cited by applicant]
US 10752951B2 · Salk et al. · 2020 [cited by applicant]
US 10793916B2 · Talasaz · 2020 [cited by applicant]
US 10801063B2 · Eltoukhy et al. · 2020 [cited by applicant]
US 10813936B2 · Arrigo et al. · 2020 [cited by applicant]
US 10815533B2 · Lee et al. · 2020 [cited by applicant]
US 10847249B2 · Sun et al. · 2020 [cited by applicant]
US 10876152B2 · Talasaz et al. · 2020 [cited by applicant]
US 10883139B2 · Eltoukhy et al. · 2021 [cited by applicant]
US 10889858B2 · Talasaz et al. · 2021 [cited by applicant]
US 10894974B2 · Talasaz et al. · 2021 [cited by applicant]
US 10907149B2 · Raymond et al. · 2021 [cited by applicant]
US 10921311B2 · Takeuchi et al. · 2021 [cited by applicant]
US 10947600B2 · Talasaz · 2021 [cited by applicant]
US 10982265B2 · Talasaz et al. · 2021 [cited by applicant]
US 10995376B1 · Talasaz · 2021 [cited by applicant]
US 11091796B2 · Talasaz et al. · 2021 [cited by applicant]
US 11142759B2 · Sabot et al. · 2021 [cited by applicant]
US 11186875B2 · Carpten et al. · 2021 [cited by applicant]
US 11186878B2 · Beeler et al. · 2021 [cited by applicant]
US 11230589B2 · Lipson et al. · 2022 [cited by applicant]
US 11319594B2 · Raymond et al. · 2022 [cited by applicant]
US 11319597B2 · Talasaz · 2022 [cited by applicant]
US 11339391B2 · Raymond et al. · 2022 [cited by applicant]
US 11525162B2 · Rabinowitz et al. · 2022 [cited by applicant]
US 11578372B2 · Hawryluk et al. · 2023 [cited by applicant]
US 11633402B2 · Kodama et al. · 2023 [cited by applicant]
US 11643694B2 · Mortimer et al. · 2023 [cited by applicant]
US 11926668B2 · Rietschel et al. · 2024 [cited by applicant]
US 20030148310A1 · Sorge · 2003 [cited by applicant]
US 20040058328A1 · Chan et al. · 2004 [cited by applicant]
US 20050032057A1 · Shoemaker · 2005 [cited by applicant]
US 20070037139A1 · Tomono et al. · 2007 [cited by applicant]
US 20070117089A1 · Croker et al. · 2007 [cited by applicant]
US 20070117224A1 · Croker et al. · 2007 [cited by applicant]
US 20070128624A1 · Gormley et al. · 2007 [cited by applicant]
US 20070172873A1 · Brenner et al. · 2007 [cited by applicant]
US 20080038782A1 · Borns · 2008 [cited by applicant]
US 20090117573A1 · Fu et al. · 2009 [cited by applicant]
US 20090143243A1 · Gunning et al. · 2009 [cited by applicant]
US 20090191563A1 · Steemers et al. · 2009 [cited by applicant]
US 20090264305A1 · Brandon et al. · 2009 [cited by applicant]
US 20100093550A1 · Stuelpnagel et al. · 2010 [cited by applicant]
US 20100273219A1 · May et al. · 2010 [cited by applicant]
US 20110014657A1 · Rigatti et al. · 2011 [cited by applicant]
US 20110160078A1 · Fodor et al. · 2011 [cited by applicant]
US 20110294689A1 · Namsaraev · 2011 [cited by applicant]
US 20110313145A1 · Sharon et al. · 2011 [cited by applicant]
US 20120157322A1 · Myllykangas et al. · 2012 [cited by applicant]
US 20120283110A1 · Shendure et al. · 2012 [cited by applicant]
US 20130288915A1 · Seligmann et al. · 2013 [cited by applicant]
US 20140100792A1 · Deciu et al. · 2014 [cited by applicant]
US 20140242581A1 · Johnson · 2014 [cited by applicant]
US 20140274731A1 · Raymond · 2014 [cited by examiner]
US 20140274740A1 · Srinivasan et al. · 2014 [cited by applicant]
US 20150046180A1 · Futscher De Deus et al. · 2015 [cited by applicant]
US 20150072344A1 · Wiley · 2015 [cited by applicant]
US 20150111757A1 · Boyden et al. · 2015 [cited by applicant]
US 20150159222A1 · Gaulis et al. · 2015 [cited by applicant]
US 20150275289A1 · Otwinowski et al. · 2015 [cited by applicant]
US 20150376700A1 · Schnall-Levin et al. · 2015 [cited by applicant]
US 20160053253A1 · Salathia et al. · 2016 [cited by applicant]
US 20160053301A1 · Raymond · 2016 [cited by examiner]
US 20170088887A1 · Makarov et al. · 2017 [cited by applicant]
US 20170096706A1 · Behlke et al. · 2017 [cited by applicant]
US 20170242960A1 · Rabinowitz et al. · 2017 [cited by applicant]
US 20170283869A1 · Fang et al. · 2017 [cited by applicant]
US 20170355984A1 · Evans et al. · 2017 [cited by applicant]
US 20170356053A1 · Otto et al. · 2017 [cited by applicant]
US 20180142234A1 · Raymond et al. · 2018 [cited by applicant]
US 20180163272A1 · Raymond et al. · 2018 [cited by applicant]
US 20180179578A1 · Raymond et al. · 2018 [cited by applicant]
US 20180245072A1 · Raymond et al. · 2018 [cited by applicant]
US 20180300449A1 · Kermani et al. · 2018 [cited by applicant]
US 20180300456A1 · Eltoukhy et al. · 2018 [cited by applicant]
US 20180363066A1 · Chalmers et al. · 2018 [cited by applicant]
US 20190032118A1 · Lipson et al. · 2019 [cited by applicant]
US 20190136301A1 · Lipson et al. · 2019 [cited by applicant]
US 20190233897A1 · Cronin et al. · 2019 [cited by applicant]
US 20200048703A1 · Chee · 2020 [cited by applicant]
US 20200299775A1 · Hawryluk et al. · 2020 [cited by applicant]
US 20210198658A1 · Raymond et al. · 2021 [cited by applicant]
US 20220073906A1 · Guo et al. · 2022 [cited by applicant]
US 20220267763A1 · Raymond et al. · 2022 [cited by applicant]
CN 101932729A · 2010 [cited by applicant]
CN 102264914A · 2011 [cited by applicant]
CN 102439177A · 2012 [cited by applicant]
CN 103103624A · 2013 [cited by applicant]
CN 103668471A · 2014 [cited by applicant]
EP 0709467A2 · 1996 [cited by applicant]
EP 0851033A1 · 1998 [cited by applicant]
EP 3192869A1 · 2017 [cited by applicant]
EP 3202915A1 · 2017 [cited by applicant]
EP 3329039A1 · 2018 [cited by applicant]
EP 3363904A2 · 2018 [cited by applicant]
EP 3421613A1 · 2019 [cited by applicant]
EP 3470533A1 · 2019 [cited by applicant]
EP 3502273A1 · 2019 [cited by applicant]
EP 3551769A2 · 2019 [cited by applicant]
EP 3567120A1 · 2019 [cited by applicant]
EP 3374525B1 · 2021 [cited by applicant]
JP 2013536679A · 2013 [cited by applicant]
JP 2014512817A · 2014 [cited by applicant]
JP 2017525371A · 2017 [cited by applicant]
JP 2019504618A · 2019 [cited by applicant]
JP 2019526257A · 2019 [cited by applicant]
JP 2020516281A · 2020 [cited by applicant]
WO WO1999011819A1 · 1999 [cited by applicant]
WO WO9923258A1 · 1999 [cited by applicant]
WO WO0222890A2 · 2002 [cited by applicant]
WO WO2004053127A1 · 2004 [cited by applicant]
WO WO2008070375A2 · 2008 [cited by applicant]
WO WO2009076238A2 · 2009 [cited by applicant]
WO WO2009091798A1 · 2009 [cited by applicant]
WO WO2009099602A1 · 2009 [cited by applicant]
WO WO2010048605A1 · 2010 [cited by applicant]
WO WO2010129937A2 · 2010 [cited by applicant]
WO WO2011156529A2 · 2011 [cited by applicant]
WO WO2012028746A1 · 2012 [cited by applicant]
WO WO2012040387A1 · 2012 [cited by applicant]
WO WO2012129363A2 · 2012 [cited by applicant]
WO WO2012138365A1 · 2012 [cited by applicant]
WO WO2012142213A2 · 2012 [cited by applicant]
WO WO2012142334A2 · 2012 [cited by applicant]
WO WO2012148477A1 · 2012 [cited by applicant]
WO WO2014052487A1 · 2014 [cited by applicant]
WO WO2014055790A2 · 2014 [cited by applicant]
WO WO2014071295A1 · 2014 [cited by applicant]
WO WO2014093330A1 · 2014 [cited by applicant]
WO WO2014093825A1 · 2014 [cited by applicant]
WO WO2014122288A1 · 2014 [cited by applicant]
WO WO2015100427 · 2015 [cited by applicant]
WO WO2015117040A1 · 2015 [cited by applicant]
WO WO2015134552A1 · 2015 [cited by applicant]
WO WO2016022833A1 · 2016 [cited by applicant]
WO WO2016028316A1 · 2016 [cited by applicant]
WO WO2016037389A1 · 2016 [cited by applicant]
WO WO2016040901A1 · 2016 [cited by applicant]
WO WO2016094853A1 · 2016 [cited by applicant]
WO WO2016109452A1 · 2016 [cited by applicant]
WO WO2017019322A1 · 2017 [cited by applicant]
WO WO2017083562A1 · 2017 [cited by applicant]
WO WO2018039463A1 · 2018 [cited by applicant]
WO WO2018064629A1 · 2018 [cited by applicant]
WO WO2018094183A1 · 2018 [cited by applicant]
WO WO2018104908A2 · 2018 [cited by applicant]
WO WO2020106906A1 · 2020 [cited by applicant]
WO WO2021163546A1 · 2021 [cited by applicant]
WO WO2022212574A1 · 2022 [cited by applicant]
Lowe et al. (Nucleic Acids Research, vol. 18, No. 7, p. 1757-1761, 1990). (Year: 1990). [cited by examiner]
[Author Unknown] “TruSeq™ RNA and DNA Library Preparation Kits v2”. Data Sheet: Illumina® Sequencing, © 2011, 2014 Illumina, Inc., Pub. No. 770-2009-039 Current as of Nov. 17, 2014, 4 pages. [cited by applicant]
Hess, et al., “Library preparation for next generation sequencing: A review of automation strategies”. Biotechnol Adv. (Jul.-Aug. 2020); 41: 107537, 14 pages. Epub Mar. 19, 2020. [cited by applicant]
Hong and Shin, “Bisulfite-Converted DNA Quantity Evaluation: A Multiplex Quantitative Real-Time PCR System for Evaluation of Bisulfite Conversion”. Front Genet. (Feb. 25, 2021); 12: 618955. eCollection 2021. [cited by applicant]
Ma, et al., “Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours”. Nature (2018); 55: 371-376. Epub Feb. 28, 2018. [cited by applicant]
Malone, et al., “Molecular profiling for precision cancer therapies”. Genome Med. (Jan. 14, 2020); 12(1): 8, 19 pages. [cited by applicant]
Manier, et al., “Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma”. Nat Commun. (Apr. 27, 2018); 9(1): 1691, 11 pages. [cited by applicant]
Wang, et al., “Enzymatic approaches for profiling cytosine methylation and hydroxymethylation”. Mol Metab. (Mar. 2022); 57: 101314. Epub Aug. 8, 2021. [cited by applicant]
Wang, et al., “Low-pass genome sequencing versus chromosomal microarray analysis: implementation in prenatal diagnosis”. Genet Med. (Mar. 2020); 22(3): 500-510. Epub Aug. 26, 2019. [cited by applicant]
Cheng Jie et al., “Construction of chlamys farreri Fosmid Library and analysis of Genomic Structure”, Journal of Ocean University of China, Jan. 2008, vol. 38(01); 078-088 and English abstract, 11 pages. [cited by applicant]
Atamaniuk, et al., “Cell-free plasma DNA: a marker for apoptosis during hemodialysis.” Clinical Chemistry (Mar. 2006), 52(3): 523-526. [cited by applicant]
[Author Unknown] “SureSelectXT Target Enrichment System for Illumina Paired-End Multiplexed Sequencing Library”. Protocol, Version C3, Sep. 2019, Agilent Technologies, © Agilent Technologies, Inc. 2010-2019, 100 pages. [cited by applicant]
Begley, Sharon, “Psst, The Human Genome Was Never Completely Sequenced. Some Scientists Say It Should Be”, STAT News, Jun. 20, 2017 (Year: 2017), downloaded Sep. 3, 2018 from https://www.statnews.com/2017 /06/20/human-g… [cited by applicant]
Beltran, et al., “Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer”. J Clin Invest (Apr. 1, 2020), 130(4): 1653-1668. [cited by applicant]
Blake, R. D. et al., “Thermodynamic effects of formamide on DNa stability”, Nucleic Acids Research, vol. 24, No. 11, Oxford University Press, 1996, 2095-2103. [cited by applicant]
Chan, et al., “Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.” Clinical Chemistry (2013),… [cited by applicant]
Cheng, et al., “Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncolog… [cited by applicant]
Extended European Search Report in Application No. EP 13862440.8, dated Oct. 11, 2016, 19 pages. [cited by applicant]
Extended European Search Report in Application No. EP 16865029.9, dated Apr. 29, 2019, 11 pages. [cited by applicant]
Extended European Search Report in Application No. EP 17844424.6, dated Mar. 27, 2020, 8 pages. [cited by applicant]
Extended European Search Report in Application No. EP 19153893.3, dated Sep. 17, 2019, 9 pages. [cited by applicant]
Extended European Search Report in Application No. EP 21152311.3, dated Sep. 7, 2021, 14 pages. [cited by applicant]
Fakruddin, et al., “Nucleic acid amplification: Alternative methods of polymerase chain reaction”. Journal of Pharmacy and Bioallied Sciences (Oct.-Dec. 2013), 5(4): 245-252. [cited by applicant]
Forster, et al., “A human gut bacterial genome and culture collection for improved metagenomic analyses”. Nat Biotechnol. (Feb. 2019), 37(2): 186-192. Epub Feb. 4, 2019. [cited by applicant]
Hoeijmakers et al., “Linear amplification for deep sequencing.” Nature Protocols (2011), 6(7): 1026-1036. [cited by applicant]
Horn, Susanne, “Target Enrichment via DNA Hybridization Capture” in Ancient DNA: Methods and Protocols, Methods in Molecular Biology (2012), 840: 177-188. Epub Dec. 8, 2011. [cited by applicant]
Jacobs, et al., “The thermal stability of oligonucleotide duplexes is sequence independent in tetraalkylammonium salt solutions: application to identifying recombinant DNA clones”. Nucleic Acids Res. (May 25, 1988), 16(… [cited by applicant]
KAPA Biosystems, “KAPA Library Quantification Kits Technical Data Sheet” (2011), 6 pages, www.kapabiosystems.com. [cited by applicant]
Leary, et al. “Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing.” Science Translational Medicine (Nov. 28, 2012), 4(162): 162ra154. [cited by applicant]
Lin, et al., “Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.” Molecular Cancer Research (Sep. 2009), 7(9): 1466-1476. Epub Sep. 8, 2009. [cited by applicant]
Mamanova, et al., “Target-enrichment strategies for next-generation sequencing”. Nature Methods. (Feb. 2010), 7(2): 111-118. [cited by applicant]
Mano, H., “Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer.” Cancer Science (Dec. 2008), 99(12): 2349-2355. Epub Nov. 20, 2008. [cited by applicant]
McKernan, et al., “Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding.” Genome Research (Sep. 2009), 19(9): 1527-1541. Epub Jun. 2… [cited by applicant]
Melchior, W.B. and Hippel, P.H. “Alteration of the relative stability of dA⋅ dT and dG. dC base pairs in DNA.” Proceedings of the National Academy of Sciences USA (Feb. 1973), 70(2): 298-302. [cited by applicant]
Meyer et al., “From micrograms to picograms: quantitative PCR reduces the material demands of high-throughput sequencing” Nucleic Acids Research (2008), 36(1): e5, 6 pages. Epub Dec. 15, 2007. [cited by applicant]
Meyer, et al., “Targeted high-throughput sequencing of tagged nucleic acid samples.” Nucleic Acids Research (2007), 35(15): e97, 5 pages. Epub Aug. 1, 2007. [cited by applicant]
Miura, et al., “Highly efficient single-stranded DNA ligation technique improves low-input whole-genome bisulfite sequencing by post-bisulfite adaptor tagging.” Nucleic Acids Research (Sep. 5, 2019), 47(15): e85-e85, p.… [cited by applicant]
Oxford Dictionary of Biochemistry and Molecular Biology, Definition of “base composition”, general eds Attwood, et al. Revised Edition (2000), 3 pages. [cited by applicant]
Partial Supplementary European Search Report in European Application No. 13862440.8 dated Jul. 4, 2016, 11 pages. [cited by applicant]
PCT/US2013/074102, International Preliminary Report on Patentability dated Jun. 16, 2015. [cited by applicant]
PCT/US2013/074102, International Search Report and Written Opinion mailed Feb. 28, 2014. [cited by applicant]
PCT/US2014/052317, International Preliminary Report on Patentability dated Feb. 28, 2017, 8 pages. [cited by applicant]
PCT/US2014/052317, International Search Report and Written Opinion mailed Jan. 13, 2015, 13 pages. [cited by applicant]
PCT/US2016/061395, International Preliminary Report on Patentability dated May 15, 2018, 10 pages. [cited by applicant]
PCT/US2016/061395, International Search Report and Written Opinion mailed Feb. 7, 2017, 14 pages. [cited by applicant]
PCT/US2017/048434, International Preliminary Report on Patentability dated Feb. 26, 2019, 10 pages. [cited by applicant]
PCT/US2017/048434, International Search Report and Written Opinion mailed Dec. 26, 2017, 15 pages. [cited by applicant]
PCT/US2021/049448, International Search Report and Written Opinion dated Dec. 28, 2021, 12 pages. [cited by applicant]
Piovesan, et al., “On the length, weight and GC content of the human genome”. BMC Res Notes (Feb. 27, 2019), 12: 106, 7 pages. [cited by applicant]
Ritti and Perbal, “Enzymes used in molecular biology: a useful guide.” Journal of Cell Communication and Signaling (2008), 2(1-2): 25-45. [cited by applicant]
Samorodnitsky, et al., “Comparison of Custom Capture for Targeted Next-Generation DNA Sequencing.” The Journal of Molecular Diagnostics (2015), 17(1): 64-75. [cited by applicant]
Shevelev and Hübscher, “The 3′ 5′ exonucleases”, Nat Rev Mol Cell Biol. (May 2002), 3(5): 364-376. [cited by applicant]
Shiroguchi, et al., “Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes.” PNAS (Jan. 24, 2012), 109(4): 1347-1352, Supporting Information, 14 pages. [cited by applicant]
Stellwagen, Earle, et al., “Monovalent cation size and DNA conformational stability.” Biochemistry (Mar. 16, 2011), 50(15): 3084-3094. [cited by applicant]
Taton, T. Andrew, et al., “Scanometric DNA array detection with nanoparticle probes.” Science (Sep. 8, 2000), 289(5485): 1757-1760. [cited by applicant]
Vogelstein, Bert, et al. “Cancer genome landscapes.” Science 339.6127 (2013): 1546-1558. [cited by applicant]
Wikipedia, “List of sequenced bacterial genomes” Wikipedia.com, accessed Jan. 24, 2014, 57 pages. (Year: 2014). [cited by applicant]
Wisegeek, “How many species of bacteria are there?” WiseGeek.com, accessed Jan. 21, 2014, 2 pages. (Year: 2014). [cited by applicant]
Yegnasubramanian et al., “Preparation of Fragment Libraries for Next-Generation Sequencing on the Applied Biosystems SOLID Platform.” Methods in Enzymology (2013), 529: 185-200. [cited by applicant]
Zhou, et al., “Systematic evaluation of library preparation methods and sequencing platforms for high-throughput whole genome bisulfite sequencing.” Scientific Reports (2019), 9: 10383, 16 pages. [cited by applicant]
Cunningham, et al., “Abstract 881. Rapid Detection of Mycoplasma pneumoniae from Clinical Specimens by Transcription-Mediated Amplification”. ICAAC 40th Anniversary, Toronto, Sep. 17-20, 2000, 2 pages. [cited by applicant]
Diaz Jr. and Bardelli, “Liquid biopsies: genotyping circulating tumor DNA”. J Clin Oncol. Feb. 20, 2014; 32(6): 579-586. Epub Jan. 21, 2014. [cited by applicant]
European Patent Application No. 19153893.3: Agilent Resolution ctDx First Technical Information, submitted with Response to Summons to Attend Oral Proceedings as “Annex B”, on Mar. 17, 2023; 50 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 1, submitted with Response to Summons to Attend Oral Proceedings, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 10, submitted with Response to Summons to Attend Oral Proceedings, on Apr. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 2, submitted with Response to Summons to Attend Oral Proceedings, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 3, submitted with Response to Summons to Attend Oral Proceedings, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 4, submitted with Response to Summons to Attend Oral Proceedings, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 5, submitted with Response to Summons to Attend Oral Proceedings, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 6, submitted with Response to Summons to Attend Oral Proceedings, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 7, submitted with Response to Summons to Attend Oral Proceedings, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 8, submitted with Response to Summons to Attend Oral Proceedings, on Apr. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Auxiliary Request 9, submitted with Response to Summons to Attend Oral Proceedings, on Apr. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Companion Diagnostics, submitted with Response to Summons to Attend Oral Proceedings as “Annex C”, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Declaration of Paul Stull with Exhibit B, signed Mar. 16, 2023, submitted with Response to Summons to Attend Oral Proceedings on Mar. 17, 2023; 8 total pages. [cited by applicant]
European Patent Application No. 19153893.3: Letter from Donna Roscoe, Ph.D. of Center for Devices and Radiological Health to Chris Pretzinger of Resolution Bioscience, Inc., signed Mar. 16, 2023, submitted with Response… [cited by applicant]
European Patent Application No. 19153893.3: Main Request, submitted with Response to Summons to Attend Oral Proceedings, on Mar. 17, 2023; 2 pages. [cited by applicant]
European Patent Application No. 19153893.3: Response to Summons to Attend Oral Proceedings, dated Mar. 17, 2023; 31 pages. [cited by applicant]
Hocking, et al., “Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies”. Cancer Biol Med. Jun. 2016; 13(2): 215-225. [cited by applicant]
Jung, et al., “Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature”. Clin Chim Acta. Nov. 11, 2010; 411(21-22): 1611-1624. Epub Aug. 2, 2010. [cited by applicant]
Kivioja, T., et al., “Counting absolute Nos. of molecules using unique molecular identifiers”, Nature Methods (Nov. 20, 2011); 9(1): 72-74. [cited by applicant]
PCT/US2021/049448, International Preliminary Report on Patentability dated Mar. 23, 2023,7 pages. [cited by applicant]
Pollak, Julia, et al., “Analytical validation of the Agilent Resolution ctDx HRD plasma assay used to identify mCRPC patients with mutations, including homozygous deletions, in DNA repair genes as a companion diagnostic… [cited by applicant]
Stull and Blanchard, “Improvement in the Dispersion of Silica Nanoparticles”. 241st ACS National Meeting, Mar. 28-31, 2011, Abstract, 1 page. [cited by applicant]
Stull and Blanchard, “Surface coatings on anisotropic nanoparticles”. 246th ACS National Meeting, Sep. 11-12, 2013, Abstract, 1 page. [cited by applicant]
[Author Unknown] “NGS Library Preparation for Whole Genome Bisulfite Sequencing (WGBS) on Illumina® Sequencing Platforms”, Qiagen, Cat # 180495 [“retrieved date unknown”] https://www.qiagen.com/us/resources/resourcedeta… [cited by applicant]
[Author Unknown] “QIAseq™ Methyl Library Handbook for DNA library construction for whole genome bisulfite sequencing on Illumina® sequencing platforms”, Qiagen, Cat # 180502 [“retrieved date unknown”] https://www.qiagen… [cited by applicant]
[Author Unknown] “QIAseq® Targeted Methyl Panel Handbook Targeted next-generation sequencing of methylated DNA”, QIAgen, Cat # 335501 [“retrieved date unknown”] https://www.qiagen.com/us/products/discovery-and-translati… [cited by applicant]
Porreca, G.J., et al., “Multiplex Amplification of Large Sets of Human Exons,” Nature Methods, Oct. 14, 2007, vol. 4 (11), pp. 931-936. [cited by applicant]
Xia et al., AFSM sequencing approach: a simple and rapid method for genome-wide SNP and methylation site discovery and genetic mapping. Scientific Reports Dec. 3, 2014; 4:7300 pp. 1-8. [cited by applicant]
[Author Unknown] “An introduction to Next-Generation Sequencing Technology”. Brochure, © 2017, Illumina, Inc., Pub. No. 770-2012-008-B, Retrieved online Aug. 7, 2022, https://www.illumina.com/content/dam/illumina-market… [cited by applicant]
Biswas, et al., “Sample quality control in agilent NGS solutions”, Agilent (2018), 1-14, URL: https://www.agilent.com/cs/library/applications/application-ngs-electrophoresis-samplequalitycontrol-tapestation-5994-0127en-… [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2022/022640, mailed Jul. 25, 2022, 15 pages. [cited by applicant]
Jang, et al., “Quality control probes for spot-uniformity and quantitative analysis of oligonucleotide array”, Journal of Microbiology and Biotechnology (2009); 19(7): 658-665. [cited by applicant]